PRC
BEAM icon

Pearl River Capital’s Beam Therapeutics BEAM Stock Holding History

Pearl River Capital’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,429
Closed -$510K – 434
2024
Q1 		$510K Buy
+15,429
New +$481K 0.08% 302
2023
Q2 		– Sell
-14,676
Closed -$449K – 487
2023
Q1 		$449K Buy
14,676
+4,036
+38% +$159K 0.07% 341
2022
Q4 		$416K Sell
10,640
-4,815
-31% -$216K 0.07% 354
2022
Q3 		$736K Sell
15,455
-2,521
-14% -$144K 0.14% 222
2022
Q2 		$696K Buy
17,976
+14,366
+398% +$571K 0.16% 202
2022
Q1 		$207K Buy
+3,610
New +$237K 0.06% 360

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Pearl River Capital's BEAM Position: Q2 2024 in Review

Pearl River Capital sold out of Beam Therapeutics (BEAM) in Q2 2024, closing a stake of 15,429 shares — an estimated $510K sold.

Pearl River Capital first reported a position in BEAM in Q1 2022 and held it in 6 quarters. The position peaked at $736K in Q3 2022. 214 funds tracked by Wall St. Rank hold BEAM as of Q2 2024.

  • Pearl River Capital reported no remaining Beam Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Pearl River Capital sold 15,429 Beam Therapeutics shares in Q2 2024, an estimated $510K.
  • Pearl River Capital first reported a position in Beam Therapeutics in Q1 2022 and held it in 6 quarters.
  • Pearl River Capital's Beam Therapeutics position peaked at $736K in Q3 2022.
  • 214 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2024.

Based on Pearl River Capital's 13F filing for Q2 2024, filed 13 Aug 2024.